lamotrigine has been researched along with Multiple Sclerosis, Chronic Progressive in 4 studies
Multiple Sclerosis, Chronic Progressive: A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report 11 MS patients with trigeminal neuralgia (TN): 6 intolerant to a therapeutic dosage of CBZ, showing serious adverse effects and subsequently treated with a combination of low-dose CBZ and gabapentin (GBP) (group 1); 5 treated with lamotrigine (LMT), showing adverse effects and subsequently treated with GBP (group 2)." | 7.70 | Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. ( Leandri, M; Mancardi, GL; Messmer Uccelli, M; Solaro, C; Uccelli, A, 2000) |
| " We report 11 MS patients with trigeminal neuralgia (TN): 6 intolerant to a therapeutic dosage of CBZ, showing serious adverse effects and subsequently treated with a combination of low-dose CBZ and gabapentin (GBP) (group 1); 5 treated with lamotrigine (LMT), showing adverse effects and subsequently treated with GBP (group 2)." | 3.70 | Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. ( Leandri, M; Mancardi, GL; Messmer Uccelli, M; Solaro, C; Uccelli, A, 2000) |
| "Treatment with lamotrigine was associated with more rashes (20% vs 5%, P value 0." | 2.52 | Sodium channel blockers for neuroprotection in multiple sclerosis. ( Hao, Z; Wen, J; Yang, C; Zeng, L; Zhang, L, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, C | 1 |
| Hao, Z | 1 |
| Zhang, L | 1 |
| Zeng, L | 1 |
| Wen, J | 1 |
| Hayton, T | 2 |
| Furby, J | 2 |
| Smith, KJ | 2 |
| Altmann, DR | 2 |
| Brenner, R | 2 |
| Chataway, J | 2 |
| Hunter, K | 2 |
| Tozer, DJ | 2 |
| Miller, DH | 2 |
| Kapoor, R | 2 |
| Solaro, C | 1 |
| Messmer Uccelli, M | 1 |
| Uccelli, A | 1 |
| Leandri, M | 1 |
| Mancardi, GL | 1 |
1 review available for lamotrigine and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Sodium channel blockers for neuroprotection in multiple sclerosis.
Topics: Disease Progression; Female; Humans; Immunosuppressive Agents; Lamotrigine; Male; Middle Aged; Multi | 2015 |
1 trial available for lamotrigine and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.
Topics: Adult; Calcium Channel Blockers; Disability Evaluation; Double-Blind Method; Female; Humans; Lamotri | 2012 |
2 other studies available for lamotrigine and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis.
Topics: Adult; Anticonvulsants; Cross-Sectional Studies; Disability Evaluation; Double-Blind Method; Female; | 2012 |
Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Res | 2000 |